Julia Murray

Voorspellers of Langetermijn Disease-Free Survival With Stereotactic Body Radiotherapie for Oligogemetastaseerd Prostaatkanker

Stereotactic Body Radiotherapie to the Prostate With Focal Boost: Analyse of the Primary Endpoint in the DELINEATE Trial Cohort E

Stereotactic Body Radiotherapie for Oligoprogressive Disease in Androgen-Suppressed Prostaatkanker: Primary Endpoint Analyse of the TRAP Trial

Observatie versus MRI-screening en preventieve behandeling van ruggenmergcompressie bij mCRPC: PROMPTS